Ruoslahti E[Author] - Search Results

Year	Number of Results
1963	1
1964	1
1965	2
1966	5
1967	2
1968	3
1969	3
1970	5
1971	4
1972	11
1973	14
1974	9
1975	9
1976	15
1977	9
1978	11
1979	10
1980	12
1981	21
1982	16
1983	12
1984	8
1985	13
1986	10
1987	15
1988	11
1989	14
1990	12
1991	8
1992	12
1993	9
1994	15
1995	8
1996	18
1997	11
1998	9
1999	11
2000	9
2001	6
2002	9
2003	8
2004	8
2005	7
2006	5
2007	5
2008	9
2009	13
2010	11
2011	14
2012	12
2013	14
2014	9
2015	7
2016	15
2017	15
2018	5
2019	6
2020	1
2021	1

1

RGD and other recognition sequences for integrins.

Ruoslahti E. Ruoslahti E. Annu Rev Cell Dev Biol. 1996;12:697-715. doi: 10.1146/annurev.cellbio.12.1.697. Annu Rev Cell Dev Biol. 1996. PMID: 8970741 Review.

2

Tumor penetrating peptides for improved drug delivery.

Ruoslahti E. Ruoslahti E. Adv Drug Deliv Rev. 2017 Feb;110-111:3-12. doi: 10.1016/j.addr.2016.03.008. Epub 2016 Apr 1. Adv Drug Deliv Rev. 2017. PMID: 27040947 Free PMC article. Review.

3

Peptide-guided nanoparticles for glioblastoma targeting.

Säälik P, Lingasamy P, Toome K, Mastandrea I, Rousso-Noori L, Tobi A, Simón-Gracia L, Hunt H, Paiste P, Kotamraju VR, Bergers G, Asser T, Rätsep T, Ruoslahti E, Bjerkvig R, Friedmann-Morvinski D, Teesalu T. Säälik P, et al. Among authors: ruoslahti e. J Control Release. 2019 Aug 28;308:109-118. doi: 10.1016/j.jconrel.2019.06.018. Epub 2019 Jun 27. J Control Release. 2019. PMID: 31255690

4

Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy.

Gregory JV, Kadiyala P, Doherty R, Cadena M, Habeel S, Ruoslahti E, Lowenstein PR, Castro MG, Lahann J. Gregory JV, et al. Among authors: ruoslahti e. Nat Commun. 2020 Nov 10;11(1):5687. doi: 10.1038/s41467-020-19225-7. Nat Commun. 2020. PMID: 33173024 Free PMC article.

5

Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.

Scodeller P, Simón-Gracia L, Kopanchuk S, Tobi A, Kilk K, Säälik P, Kurm K, Squadrito ML, Kotamraju VR, Rinken A, De Palma M, Ruoslahti E, Teesalu T. Scodeller P, et al. Among authors: ruoslahti e. Sci Rep. 2017 Nov 7;7(1):14655. doi: 10.1038/s41598-017-14709-x. Sci Rep. 2017. PMID: 29116108 Free PMC article.

6

Integrin signaling.

Giancotti FG, Ruoslahti E. Giancotti FG, et al. Among authors: ruoslahti e. Science. 1999 Aug 13;285(5430):1028-32. doi: 10.1126/science.285.5430.1028. Science. 1999. PMID: 10446041 Review.

7

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E. Sugahara KN, et al. Among authors: ruoslahti e. Cancer Cell. 2009 Dec 8;16(6):510-20. doi: 10.1016/j.ccr.2009.10.013. Cancer Cell. 2009. PMID: 19962669 Free PMC article.

8

Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.

Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Greenwald DR, Ruoslahti E. Sugahara KN, et al. Among authors: ruoslahti e. Science. 2010 May 21;328(5981):1031-5. doi: 10.1126/science.1183057. Epub 2010 Apr 8. Science. 2010. PMID: 20378772 Free PMC article.

9

Integrins.

Ruoslahti E. Ruoslahti E. J Clin Invest. 1991 Jan;87(1):1-5. doi: 10.1172/JCI114957. J Clin Invest. 1991. PMID: 1985087 Free PMC article. Review. No abstract available.

10

Fibronectin.

Ruoslahti E. Ruoslahti E. J Oral Pathol. 1981 Feb;10(1):3-13. doi: 10.1111/j.1600-0714.1981.tb01242.x. J Oral Pathol. 1981. PMID: 6782207 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results